RT Journal Article
SR Electronic
T1 Neurocognitive measures of self-blame and risk prediction models of recurrence in major depressive disorder
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.13.21249739
DO 10.1101/2021.01.13.21249739
A1 Lawrence, Andrew J.
A1 Stahl, Daniel
A1 Duan, Suqian
A1 Fennema, Diede
A1 Jaeckle, Tanja
A1 Young, Allan H.
A1 Dazzan, Paola
A1 Moll, Jorge
A1 Zahn, Roland
YR 2021
UL http://medrxiv.org/content/early/2021/01/15/2021.01.13.21249739.abstract
AB Background Overgeneralised self-blaming emotions, such as self-disgust, are core symptoms of major depressive disorder (MDD) and prompt specific actions (i.e. “action tendencies”), which are more functionally relevant than the emotions themselves. We have recently shown, using a novel cognitive task, that when feeling self-blaming emotions, maladaptive action tendencies (feeling like “hiding” and like “creating a distance from oneself”) and an overgeneralised perception of control are characteristic of MDD, even after remission of symptoms. Here, we probed the potential of this cognitive signature, and its combination with previously employed fMRI measures, to predict individual recurrence risk. For this purpose, we developed a user-friendly hybrid machine-/statistical-learning tool which we make freely available.Methods 52 medication-free remitted MDD patients, who had completed the Action Tendencies Task and our self-blame fMRI task at baseline, were followed up clinically over 14-months to determine recurrence. Prospective prediction models included baseline maladaptive self-blame-related action tendencies and anterior temporal fMRI connectivity patterns across a set of fronto-limbic a priori regions of interest, as well as established clinical and standard psychological predictors. Prediction models used elastic-net regularised logistic regression with nested 10-fold cross-validation.Results Cross-validated discrimination was highly promising (AuC≥0.86), and positive predictive values over 80% were achieved when including fMRI in multi-modal models, but only up to 71% (AuC≤.74) when solely relying on cognitive and clinical measures.Conclusions This shows the high potential of multi-modal signatures of self-blaming biases to predict recurrence risk at an individual level, and calls for external validation in an independent sample.Competing Interest StatementRZ is a private psychiatrist service provider at The London Depression Institute, has collaborated with e-health companies Depsee Ltd, EMIS PLC and Alloc Modulo Ltd. He has received honoraria from pharmaceutical companies (Lundbeck, Janssen) for scientific presentations and is a co-investigator for a Livanova-funded study on Vagus Nerve Stimulation. None of the other authors report biomedical financial interests or potential conflicts of interest related to the subject of this paper.Funding StatementThis study was funded by an MRC Clinician Scientist Fellowship to RZ (G0902304). RZ and DS were partly and AJL fully funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London and by a NARSAD Independent Investigator Grant (24715) from the Brain & Behavior Research Foundation. J.M. was supported by the LABS-D'Or Hospital Network, Rio de Janeiro, Brazil. J.A.G. This study was funded by the UK Medical Research Council (G0902304). D.F. was funded by the Medical Research Council Doctoral Training Partnership (Ref: 2064430).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This research was approved by the South Manchester National Health Service Research Ethics Committee. All participants have given written informed consent after the procedures of the study have been fully explained.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe dataset used in this publication is available upon request, subject to a Data Access Agreement. http://doi.org/doi:10.18742/RDM01-482